Foreign-Invested Companies Dominate Chinese Expanding OTC Drug Market
This article was originally published in PharmAsia News
Foreign-invested pharmaceutical companies are dominating China's expanding OTC drug market, whose scale surged from $19 billion in 1990 to $129.5 billion in 2008, due mainly to the country's increasing living standards, aged population and focus on healthcare services
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.